Concepedia

Esther Natalie Olíva

EN

37

Publications

2K

Citations

23

H-Index

2001

Active since

Affiliations

Azienda ospedaliera "Bianchi-Melacrino-Morelli"(Current)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Sapienza University of Rome

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

Esther Natalie Olíva is an author at Azienda ospedaliera "Bianchi-Melacrino-Morelli" specializing in medicine, hematology, and health sciences.

ORCID

Top concepts

Publications per year

2001–2023

37

Publications

37

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer et al. · Journal of Clinical Oncology · 2021 · 212 citations · Full text

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 159 citations · Full text

, , +7

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

Pierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti et al. · Leukemia · 2018 · 159 citations · Full text

Azacitidine for the treatment of patients with acute myeloid leukemia

Luca Maurillo, Adriano Venditti, Alessandra Spagnoli et al. · Cancer · 2011 · 144 citations

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

Uwe Platzbecker, Argiris Symeonidis, Esther Natalie Olíva et al. · Leukemia · 2017 · 126 citations · Full text

Rows per page

1–5 of 37